Ge W D, Tan L, Tao Z Z, Xu Y
Department of Otolaryngology Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Jan 5;32(1):33-36. doi: 10.13201/j.issn.1001-1781.2018.01.007.
To investigate the clinical effect of nasal spray type allergen blocker combined with oral antihistamine on dust mite allergic allergic rhinitis (AR). Ninety cases of patients withmild-severe allergic to dust mite were randomly divided into experimental group and control group, 45 cases in each group. The experimental group used nasal spray allergen barrier agent combined with citrate tablets, and the control group used physiological seawater combined with citrate sheet. The symptoms of subjective rhinitis, objective signs, improvement of quality of life scores and adverse reactionsof 2 groups were evaluated before and 2 weeks after treatment. The symptoms, signs and quality of life of the patients in the experimental group were better than those in the control group (<0.05). No obvious adverse reactions were observed. The effect of nasal spray type allergen blocker combined with antihistamine on AR patients with allergic to dust mite is remarkable. They can significantly alleviate the symptoms and signs of rhinitis in patients, and is worthy to be popularized in clinical application.
探讨鼻喷型变应原阻断剂联合口服抗组胺药治疗尘螨过敏性鼻炎(AR)的临床效果。将90例轻 - 重度尘螨过敏患者随机分为实验组和对照组,每组45例。实验组使用鼻喷变应原阻隔剂联合枸橼酸片,对照组使用生理性海水联合枸橼酸片。分别于治疗前及治疗2周后评估两组患者的鼻炎主观症状、客观体征、生活质量评分改善情况及不良反应。实验组患者的症状、体征及生活质量均优于对照组(P<0.05)。未观察到明显不良反应。鼻喷型变应原阻断剂联合抗组胺药治疗尘螨过敏AR患者效果显著,可明显减轻患者鼻炎的症状和体征,值得临床推广应用。